![color cloud.png](https://static.wixstatic.com/media/349100_c1d0ab08c11e43d6b6320bc2d5ff30fc~mv2.png/v1/crop/x_243,y_0,w_2736,h_1765/fill/w_738,h_476,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/color%20cloud.png)
![](https://static.wixstatic.com/media/349100_c785e218c29f4521b536957129d2f847~mv2.jpg/v1/fill/w_392,h_392,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Image-empty-state.jpg)
Bernard Lerer
Hadassah Medical Center, Hebrew University
Israel
Bernard Lerer is Professor of Psychiatry and Head of Hadassah BrainLabs (https://brainlabs.org.il/) at Hadassah – Hebrew University Medical Center in Jerusalem. He was trained at the University of Cape Town Medical School, Hadassah Medical Center and Herzog Hospital, Jerusalem and was a post-doctoral research fellow with Prof. Samuel Gershon at Lafayette Clinic, Wayne State University, Detroit. His main research interest is the neurochemical mechanisms of antidepressants, mood stabilizers and brain stimulation as a basis for novel drug development. Recently, he has established a comprehensive preclinical and translational program focused on the psychiatric applications of psychedelic drugs. He has 386 PubMed listed original scientific publications and has edited 4 books. He has received numerous awards, most recently the 2019 Lifetime Achievement Award of the International Society for Affective Disorders (ISAD). He was Founding Editor-in-Chief of the International Journal of Neuropsychopharmacology (1998-2008). Bernard Lerer holds several patents in psychopharmacology and pharmacogenetics and has mentored more than 100 PhD and MSc students and psychiatrist research trainees.